Stay current on changes and developments in corporate law with a wide variety of resources and tools.
A former accountant for Celator Pharmaceuticals Inc. shared with three other men some inside “juice” about the New Jersey company’s $1.5 billion acquisition before it happened, U.S. authorities said Aug. 31 ( SEC v. Kita, D.N.J., 3:17-cv-06602, 8/31/17 ).
Evan Kita of Yardley, Pa., pleaded guilty to federal securities fraud and conspiracy charges in connection with illicit trading on Celator’s 2016 purchase by Jazz Pharmaceuticals PLC and its positive clinical trials for a cancer drug, the Department of Justice said. He allegedly tipped two friends about the news. One of them tipped his father, the DOJ said.
Yardley resident Daniel Perez, one of the friends, was arrested and charged with conspiracy to commit securities fraud. The other friend, Richard Yu of Pennington, N.J., pleaded guilty to securities fraud. His father, Pennington resident Chiang Yu, also pleaded guilty to securities fraud.
Kita admitted to gains of between $250,000 and $550,000 from his scheme, according to the DOJ. Chiang Yu acknowledged his offense earned between $95,000 and $150,000, while his son confessed to about $200,000 secured from his role in the scheme, the department said.
Conspiracy to commit securities fraud can bring up to five years in prison and a $250,000 fine. Securities fraud comes with the potential for 20 years in prison and a $5 million fine.
The Securities and Exchange Commission also brought parallel civil charges against the four men.
After leaving Celator in April 2016, Kita received a text message from an unnamed friend there describing “some juice” about the company’s upcoming acquisition, according to the SEC. Kita then used an encrypted smartphone application to tell Perez and Richard Yu that Celator’s stock was “gonna pop,” the agency said.
Kita, while at Celator, also tipped Perez and Richard Yu about the positive results from the clinical trials for Vyxeos, which treats myeloid leukemia, according to the commission.
Chiang Yu received both tips about the acquisition and the cancer drug from his son, the SEC said.
''The investing public relies on accountants and other gatekeepers to safeguard confidential information, not use it for personal profit,’' Kelly Gibson, associate director of the SEC’s Philadelphia Regional Office, said in a statement. ''When gatekeepers violate that public trust as Kita allegedly did, the SEC is committed to holding them accountable.’'
Robert Heim of Meyers & Heim LLP in New York, who is representing Kita, told Bloomberg BNA his client “made a terrible mistake, which he is very remorseful for.” Kristen Santillo of Krovatin Klingeman LLC in Newark, N.J., who is representing Chiang Yu, told Bloomberg BNA he “regrets his illegal trading, and has taken responsibility.” Attorney Louis Busico in Newtown, Pa., who is representing Perez, said his client “strongly maintains his innocence and looks forward to clearing his name at trial.”
A lawyer for Richard Yu didn’t immediately respond to a request for comment.
To contact the reporter on this story: Andrew Ramonas in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Phyllis Diamond at email@example.com
To view this complaint, visit: https://www.sec.gov/litigation/complaints/2017/comp-pr2017-151.pdf
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)